Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELE L PORTER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1669776803
CMS profile
10539988
Location
VIRGINIA BEACH, VA

General Payments · PY2021–2024

$1,484.62

  • Reported across 28 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$764.84

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $764.84 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $384.09 5
Lilly USA, LLC $150.21 4
Astellas Pharma US Inc $124.93 1
PFIZER INC. $59.22 3
Exact Sciences Corporation $46.39 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $89.65 1
PY2022 $275.42 6
PY2023 $354.71 6
PY2024 $764.84 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $124.93 03/07/2024 Food and Beverage Undisputed 01/23/2026 1139525618 CMS
AstraZeneca Pharmaceuticals LP $122.77 01/24/2024 Food and Beverage Undisputed 01/23/2026 1104765644 CMS
AstraZeneca Pharmaceuticals LP $114.84 02/22/2024 Food and Beverage Undisputed 01/23/2026 1104783424 CMS
AstraZeneca Pharmaceuticals LP $15.60 05/08/2024 Food and Beverage Undisputed 01/23/2026 1104710769 CMS
AstraZeneca Pharmaceuticals LP $14.82 07/31/2024 Food and Beverage Undisputed 01/23/2026 1105516789 CMS
AstraZeneca Pharmaceuticals LP $116.06 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104403495 CMS
Exact Sciences Corporation $21.44 09/25/2024 Food and Beverage Undisputed 01/23/2026 1114498510 CMS
Exact Sciences Corporation $24.95 12/11/2024 Food and Beverage Undisputed 01/23/2026 1114498515 CMS
Lilly USA, LLC $120.60 03/13/2024 Food and Beverage Undisputed 01/23/2026 1135825869 CMS
Lilly USA, LLC $11.36 07/08/2024 Food and Beverage Undisputed 01/23/2026 1135836204 CMS
Lilly USA, LLC $8.71 08/02/2024 Food and Beverage Undisputed 01/23/2026 1135836208 CMS
Lilly USA, LLC $9.54 09/25/2024 Food and Beverage Undisputed 01/23/2026 1135746724 CMS
PFIZER INC. $20.69 03/21/2024 Food and Beverage Undisputed 01/23/2026 1131214356 CMS
PFIZER INC. $23.68 09/13/2024 Food and Beverage Undisputed 01/23/2026 1131848198 CMS
PFIZER INC. $14.85 10/30/2024 Food and Beverage Undisputed 01/23/2026 1132086230 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.